ArticleOncotarget2017

Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.

Costantine Albany et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.